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        Plasmacytoid DCs (pDCs) are potent antiviral ef-
fector cells that were originally identifi  ed by their 
plasma cell  –  like morphology and localization 
within the T cell zone of lymphoid tissue (  1  ). Also 
termed type I IFN-producing cells, pDCs secrete 
more type I IFN on a per-cell basis than any other 
cell type (  2  –  4  ). pDCs are especially important in 
controlling viral infections, a property highlighted 
by their selective expression of Toll-like receptor 
(TLR) 7 and TLR9 (  5  ), which recognize single-
stranded RNA and double-stranded DNA, re-
spectively. pDCs do not express TLR2, TLR3, 
TLR4, and TLR5, explaining why they do not 
respond to common bacterial products recog-
nized by other APCs. 
  pDCs represent a rare cell type constituting 
    1% of bone marrow or splenic leukocytes and 
  <  0.5% of lymph node and peripheral blood leu-
kocytes. However, their frequency varies be-
tween mouse strains with 129Sv mice possessing 
a signifi  cantly higher proportion of pDCs than 
other mouse strains (  6  ). Mouse pDCs do not 
express the lineage markers CD19, CD3, DX5, 
CD14, or TER119 (  7, 8  ). In addition to their 
selective pattern of TLR expression, pDCs and 
myeloid DCs (mDCs) are dissimilar in various 
other aspects. Unlike mDCs, pDCs are char-
acterized by a CD11b       B220  +  Ly6C  +   phenotype 
(  7  ). Like mDCs, pDCs express CD11c but they 
do so at a lower level (  8  ). Resting pDCs have 
been referred to as immature APCs because 
they express only low levels of CD86 and class 
II MHC, and they display little or no endocytic 
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  Plasmacytoid dendritic cells (pDCs) are an important source of type I interferon (IFN) 
during initial immune responses to viral infections. In mice, pDCs are uniquely characterized 
by high-level expression of Ly49Q, a C-type lectin-like receptor specifi  c for class I major 
histocompatibility complex (MHC) molecules. Despite having a cytoplasmic immunoreceptor 
tyrosine-based inhibitory motif, Ly49Q was found to enhance pDC function in vitro, as pDC 
cytokine production in response to the Toll-like receptor (TLR) 9 agonist CpG-oligonucleotide 
(ODN) could be blocked using soluble monoclonal antibody (mAb) to Ly49Q or H-2K  b  . 
Conversely, CpG-ODN  –  dependent IFN-     production by pDCs was greatly augmented upon 
receptor cross-linking using immobilized anti-Ly49Q mAb or recombinant H-2K  b   ligand. 
Accordingly, Ly49Q-defi  cient pDCs displayed a severely reduced capacity to produce cyto-
kines in response to TLR7 and TLR9 stimulation both in vitro and in vivo. Finally, TLR9-
dependent antiviral responses were compromised in Ly49Q-null mice infected with mouse 
cytomegalovirus. Thus, class I MHC recognition by Ly49Q on pDCs is necessary for optimal 
activation of innate immune responses in vivo. 
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are thought to represent immature cells, such that acquisition 
of Ly49Q expression is linked to sequential development of 
functional pDCs (  11, 19  ). These Ly49Q        pDCs do not re-
spond to certain stimuli and are defective in the secretion of 
some cytokines. Ly49Q levels correlate well with pDC matu-
ration, and receptor acquisition is further up-regulated by 
various stimuli, including IFN-     (  17, 19  ). In some but not all 
inbred mouse strains, a subset of mDCs also expresses low 
levels of Ly49Q (  17  ). 
  We recently identifi  ed the classical class I MHC molecule, 
H-2K  b  , as the cognate Ly49Q ligand (  21  ). Using reporter cell 
analysis, a high-affi   nity ligand for Ly49Q was detected on tu-
mor and normal ex vivo cells derived from H-2  b   haplotype 
mice (B6 and 129) but not on cells from the other mouse MHC 
haplotypes tested. Direct MHC surveillance by pDCs and the 
implications of this interaction for innate immunity remain to 
be investigated. 
  The current study demonstrates a major role for Ly49Q  – 
H-2K  b   interactions in pDC production of IFN-     and, to a 
lesser extent, IL-12. Remarkably, the function of Ly49Q on 
pDCs appears to be stimulatory in nature, as revealed by cross-
linking experiments despite the presence of a cytoplasmic ITIM. 
To confi  rm these in vitro fi  ndings and to ascertain the role of 
Ly49Q during immune responses, Ly49Q-null mice were gen-
erated and characterized. Ly49Q-null mice exhibit a severe de-
fect in systemic IFN-     production after challenge with agonists 
and pathogens recognized by TLR7 and TLR9, which trans-
lates into weaker antiviral responses in vivo. We propose that 
Ly49Q recognition of self-MHC is necessary to regulate pDC 
cytokine responses to pathogens. 
    RESULTS   
  Ly49Q interactions with class I MHC are necessary 
for IFN-     secretion by pDCs 
  We have previously shown that H-2K  b   is a ligand for Ly49Q 
(  21  ), suggesting that pDC function may be regulated by class I 
MHC. Therefore, we investigated the infl  uence of Ly49Q  –
  class I MHC interactions on type I IFN secretion by pDCs in 
response to innate immune stimuli. As previously reported, 
overnight culture of splenic pDCs (129S1 strain) in the pres-
ence of CpG-oligonucleotide (ODN resulted in robust IFN-     
production (  6  ). However, when blocking mAb (  21  ) specifi  c 
for either Ly49Q or H-2K  b   were added at the initiation of cell 
cultures, IFN-     secretion by pDCs was almost completely ab-
rogated (  Fig. 1 A  ).   IL-12 secretion by pDCs could also be 
blocked using Ly49Q or H-2K  b   mAb (  Fig. 1 B  ). Thus, inter-
action of the ITIM-containing Ly49Q receptor with cognate 
H-2K  b   ligand appears to be necessary for effi   cient TLR9-in-
duced cytokine production by pDCs. 
  To test the possibility that Ly49Q is directly involved in 
activating pDCs and stimulating IFN-     production upon re-
ceptor ligation, plate-bound mAb-mediated cross-linking ex-
periments were used. Because pDCs from B6 mice are low 
producers of type I IFN compared with 129 mice (  6  ), B6 pDCs 
were selected to enhance detection of increased IFN secretion. 
As previously reported, B6 pDCs cultured in the presence of 
activity. However, upon TLR stimulation all three of these 
characteristics are up-regulated to allow pDCs to present an-
tigenic peptides and optimally stimulate CD4  +   T cell function 
(  7  ). In addition, pDCs have been implicated in promoting 
mDC maturation and terminal B cell diff  erentiation to func-
tional antibody-producing plasma cells (  1  ). Five diff  erent mAb 
reagents have been reported to specifi  cally recognize mouse 
pDCs: 120G8 (  6  ), mouse PDC antigen 1 (mPDCA-1), 440c 
(  9  ), NS-34 (  10  ), and 2E6 (  11  ). The 440c mAb recognizes Si-
glec-H, a DAP12-coupled receptor that inhibits pDC func-
tion, including IFN-     secretion (  12  ). 120G8 and mPDCA-1 
both recognize bone marrow stromal cell antigen 2 (BST2) 
(  13  ). NS-34 and 2E6 recognize Ly49Q, a member of the type 
II C-type lectin-like Ly49 family. Interestingly, most other 
Ly49 family members are exclusively expressed on NK, NKT, 
and T cell subsets, where they are known to regulate cytokine 
production and cell-mediated cytotoxicity via interactions 
with cognate class I MHC  –  related ligands on target cells. 
  Ly49Q is one of the more distantly related Ly49 family 
members, yet the receptor itself is highly conserved among 
three mouse haplotypes (C57BL/6 [B6], 129S6, and BALB/c) 
(  14  –  16  ). To date, Ly49Q protein has been detected in all mouse 
strains tested (  17  ), suggesting an important and conserved func-
tion for this receptor. The   Ly49q   gene defi  nes the centromeric 
end of the B6, 129S6, and BALB/c   Ly49   gene clusters. Inter-
estingly, a homologous segment comprising   Ly49q  - and   Ly49e  -
like genes is repeated three times in the 129S6 genome because 
of gene duplication (  18  ). Therefore, in addition to   Ly49q  1    , the 
129-related mouse strains contain   Ly49q  2     and   Ly49q  3    , but the 
latter two genes are considered pseudogenes because they lack 
exons 6 and 7, which encode the ligand-binding domain (  18  ). 
  Ly49Q was fi  rst reported to be expressed at low levels on 
a proportion of Gr-1  +   bone marrow myeloid precursor cells, 
on peripheral blood neutrophils (Gr1  +  CD11b  +  ), and on IFN-
      –  activated macrophages (  10  ). However, the function of the 
receptor on these cell types remains unknown. Ly49Q con-
tains a cytoplasmic immunoreceptor tyrosine-based inhibition 
motif (ITIM), whereas it lacks a positively charged transmem-
brane residue, both of which are characteristics of inhibitory 
Ly49 receptors expressed by NK cells. Furthermore, similar to 
inhibitory Ly49 NK receptors, the Ly49Q ITIM has been re-
ported to associate with the Src homology phosphatases 
(SHPs) 1/2 upon antibody-mediated cross-linking of the re-
ceptor (  10  ). However, Ly49Q is not expressed by NK cells. 
Moreover, Ly49Q cross-linking on activated macrophages 
has been reported to induce cytoskeletal rearrangement lead-
ing to formation of polarized fi  lopodia and lamellopodia; this 
suggests a role for Ly49Q in macrophage migration and 
phagocytosis (  10  ). 
  In subsequent reports, a population of cells expressing sig-
nifi  cantly higher levels of Ly49Q than neutrophils and mac-
rophages was identifi  ed (  11, 17, 19  ). This cell population was 
originally defi  ned as CD11c  +  B220  +  Gr1  low   and has been con-
fi   rmed to represent pDCs (  1, 20  ). Virtually all peripheral 
pDCs and the majority of bone marrow pDCs express Ly49Q. 
The subset of bone marrow pDCs lacking Ly49Q expression JEM VOL. 205, December 22, 2008 
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  Targeted disruption of the   Ly49q  1     gene 
  To confi  rm the role of Ly49Q in pDC function, we sought 
to determine the eff  ect of Ly49Q defi  ciency by targeted gene 
disruption in vivo. The   Ly49q  1     gene was disrupted in 129-
background embryonic stem (ES) cells by inserting a fl  oxed 
neomycin cassette into the StuI site of exon 2 adjacent to the 
ITIM coding region (  Fig. 2 A  ).   Founder mice shown to carry 
the   Ly49q  1    lox     allele and to exhibit germline competence were 
bred to 129S1 females. The resulting heterozygous off  spring 
were interbred and genotyped by PCR or Southern blotting 
(  Fig. 2, B  –  D  ). Note that the   Ly49q  1     probe also detects the 
closely related   Ly49q  2     and   q  3     pseuodogenes of the 129 gene 
cluster, as all three genes display the same WT KpnI fragment 
(  Fig. 2 B  ). However, mice heterozygous or homozygous for 
the   Ly49q  1    neo     or   Ly49q  1    lox     alleles are easily distinguished by 
PCR using   Ly49q  1    -specifi  c primers that do not detect the 
  Ly49q  2     or   q  3     pseuodogenes (  Fig. 2, C and D  ). 
  The insertion of a   PGK-neo   cassette or   loxP   site into exon 
2 did not eliminate transcription, as revealed by RT-PCR 
(unpublished data). Analysis of the targeted cDNA revealed 
that insertion of   PGK-neo   or   loxP   interrupted the open read-
ing frame, leading to premature termination. Both pDCs and 
mDCs from   Ly49q  1    neo/neo     and   Ly49q  1    lox/lox     mice lack any de-
tectable Ly49Q by fl  ow cytometry (  Fig. 2 E   and not de-
picted). We have reported that, in addition to pDCs, 
neutrophils also express low levels of Ly49Q protein (  10  ). 
  Ly49q  1    lox/lox     blood neutrophils lacked all detectable reactivity 
with anti-Ly49Q mAb (unpublished data), confi  rming that 
CpG-ODN produced low levels of IFN-    . In contrast, when 
B6 pDCs were cultured on immobilized Ly49Q mAb, IFN-     
production was increased 10  –  15-fold (  Fig. 1 C  ). IFN-     secre-
tion was also induced using immobilized recombinant ligand 
(K  b  :Ig/OVA) showing that MHC directly activates pDCs. 
When this experiment was repeated with 129S1-derived pDCs, 
anti-Ly49Q cross-linking also signifi   cantly increased IFN-     
production in response to CpG-ODN, albeit to a lesser extent 
(  Fig. 1 E  ). Collectively, these results suggest that pDCs are syn-
ergistically activated by class I MHC and TLR9 ligands. 
  The activation of pDCs through Ly49Q, an ITIM-bear-
ing receptor, contrasts with the established functions of similar 
receptors in lymphocytes. However, our fi  ndings are comple-
mentary to those of recent studies reporting that immunore-
ceptor tyrosine-based activation motif (ITAM)-coupled 
receptors inhibit pDC activation, specifi  cally IFN-     produc-
tion (  12, 22  ). To determine the outcome of simultaneous 
ITIM- and ITAM-mediated signal transduction in pDCs, pu-
rifi  ed cells were cultured in the presence of CpG-ODN on 
immobilized anti-Ly49Q, anti  –  Siglec-H (a DAP12-coupled 
receptor), or both. Using both B6- and 129-derived pDCs, 
inhibitory Siglec-H cross-linking blocked Ly49Q activation 
and suppressed IFN-     secretion (  Fig. 1, D and E  ). Notably, 
the reported inhibitory eff  ect of anti  –  Siglec-H was only seen 
with 129-derived pDCs, likely because of the larger basal 
IFN-     response seen using 129 versus B6 strain pDCs. Thus, 
ITAM-mediated inhibitory signals appear to be dominant and 
suppress ITIM-mediated stimulatory signals in pDCs. 
    Figure 1.         Ly49Q  –  H-2K  b   interactions are necessary for pDC cytokine secretion after TLR9 stimulation.   (A and B) Splenic pDCs from 129S1 mice 
were isolated using mPDCA-1 microbeads and cultured overnight in the presence or absence of CpG-ODN and the indicated mAb. The supernatant was 
assayed by ELISA for IFN-     (A) or IL-12p70 (B). (C  –  E) Splenic pDCs from B6 (C and D) or 129S1 (E) mice were isolated with mPDCA-1 microbeads and 
cultured overnight in wells that had been precoated with the indicated mAb or recombinant MHC molecule in the presence or absence of 10   μ  g/ml CpG. 
The supernatant was assayed by ELISA for IFN-    . Isotype control antibodies for anti-Ly49Q, anti  –  H-2K  b  , and K  b  :Ig/OVA are rIgG  2a ,  mIgG 2a  , and mIgG  1 , 
respectively. Anti-Ly49Q mAb 2E6 was used for these experiments. Data are presented as the mean of triplicate samples (error bars = SD). Results are 
representative of at least three independent experiments. ND, not detectable.     3190 L  Y  49Q REGULATION OF   P  DC FUNCTION   | Tai et al. 
Ly49Q-WT pDCs (unpublished data). As   Ly49q  2     and   q  3     are 
likely pseudogenes,   Ly49q  1     will be referred to as   Ly49q   hereaf-
ter. Unless otherwise stated, all experiments were performed 
with   Ly49q  wt/wt     (WT) or   Ly49q  lox/lox     (Ly49Q-null) littermates 
in the high IFN-producing 129 background. 
  Hematopoiesis and pDC development in Ly49Q-null mice 
  Fresh splenic pDCs are round cells with eccentric kidney-
shaped nuclei, as visualized by Giemsa stain (  Fig. 3 A  ).   After 
activation with CpG-ODN, pDCs were larger and displayed a 
higher cytoplasmic to nucleus content, and the cytoplasm also 
appeared more vacuolated. The size and morphology of rest-
ing or activated pDCs from Ly49Q-WT and -null mice were 
similar. To determine whether the localization of Ly49Q-null 
Ly49Q is normally expressed at low levels on this cell type. 
Collectively, these data demonstrate that the open reading 
frame of   Ly49q  1     was disrupted successfully. 
  The eff  ect of introducing   PGK-neo   or a   loxP   site in   Ly49q  1     
on neighboring gene expression was assessed by fl  ow cytometry 
on both resting and IL-2  –  cultured NK cells with mAb recog-
nizing proteins encoded by genes 5     (  Ly49g  ,   Ly49r  , and   Ly49e/s  ) 
and 3     (  Nkg2a/c/e   and   Nkg2d  ) of   Ly49q  1    . Both the distribution 
and lmean fl  uorescence intensity (MFI) of these receptors were 
the same on   Ly49q  wt/wt    ,   Ly49q  neo/neo    , and   Ly49q  lox/lox     NK cells 
(unpublished data). This indicates that the targeted insertion 
had no secondary eff  ect on other genes located within the 
natural killer gene complex. Furthermore, Ly49Q-null pDC 
H-2K  b   and H-2D  b   surface levels were identical to those of 
    Figure 2.         Generation of Ly49Q-null mice.   (A)   Ly49q  1    gene disruption strategy. A 10-kb segment encompassing exons 1  –  4 was cloned by recom-
bineering from BAC DNA, and a fl  oxed   PGK-Neo  r    ( neo  r   ) cassette was inserted into exon 2. After electroporation and selection, an ES clone possessing the 
predicted KpnI (K) fragment, as verifi  ed by Southern blotting, was electroporated with CMV-Cre plasmid, and the deletion of   PGK-Neo  r    was  confi  rmed by 
PCR. Both   Ly49q  1  neo    and   Ly49q  1  lox    mice were created. PCR primers are shown by arrowheads. Boxes denote exons, and the location of the Southern probe 
is underlined. (B) Southern blot analysis. Genomic tail DNA of pups from   Ly49q  1  neo/wt    parent mice was digested with KpnI and analyzed by Southern blot-
ting with the probe depicted in A. Note that the probe detects identical fragments from   Ly49q  1  ,   q  2   , and   q  3    genes. (C) PCR analysis of tail DNA from mice 
in B. To eliminate confusion caused by   Ly49q  2    and   q  3    genes,   Ly49q  1  -specifi  c primers were designed. These primers were used to analyze tail DNA by PCR 
and to differentiate between   Ly49q  1  wt    and   Ly49q  1  neo    alleles. (D) PCR analysis of pups from   Ly49q  1  lox/wt    parent mice. Tail DNA was PCR amplifi  ed with prim-
ers fl  anking exon 2 to differentiate   Ly49q  1  wt    and   Ly49q  1  lox    alleles. (E) Lack of Ly49Q protein on DCs derived from Ly49Q-null mice. Ly49Q-null and -WT 
splenocytes were stained with a combination of mAb to CD11c/B220 (top) or Siglec-H/BST2 (bottom), and Ly49Q-specifi  c mAb NS-34 or an isotype con-
trol. Ly49Q mAb staining intensity relative to isotype control mAb on gated cells is shown.     JEM VOL. 205, December 22, 2008 
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pDCs is normal, three-color immunofl  uorescent staining us-
ing mPDCA-1, CD3, and CD19 mAbs was performed on 
splenic sections from untreated and CpG-ODN  –  treated ani-
mals. In the spleens of untreated animals, pDCs were mainly 
localized within the T cell zones and in lower numbers within 
marginal zone and red pulp (  Fig. 3 B  ). In CpG-ODN  –  treated 
animals, the number of pDCs was increased and they tended 
to form clusters (  Fig. 3 B  ). The majority of CpG-activated 
pDCs were found within the marginal zone and red pulp, as 
previously reported (  23  ). Thus, no signifi  cant diff  erences were 
observed in the localization of pDCs in WT and Ly49Q-null 
mice before or after CpG-ODN treatment. 
  The potential eff  ect of Ly49Q absence on pDC frequency 
and distribution of cells in primary and secondary lymphoid or-
gans was investigated in the Ly49Q-null mice. The pDC popu-
lation as defi  ned by CD11c  +  Siglec-H  +   showed no signifi  cant 
diff  erence in the proportion and total number of pDCs in the 
spleen, mesenteric lymph nodes, or bone marrow of young 
mice (6 wk old;   Fig. 3 C   and not depicted). However, in older 
mice (  >  9 mo old) there was approximately a twofold increase 
in the proportion and total number of pDCs in these organs 
(  Fig. 3 C   and not depicted). Myeloid lineage cells in various or-
gans have been reported to express Ly49Q. There were no sig-
nifi  cant  diff   erences in the percentage and total number of 
CD11b  +  Gr-1  +   cells in the bone marrow, spleen, or lymph 
nodes in either young or old mice (unpublished data). Similarly, 
blood neutrophil numbers and proportion in WT mice and 
Ly49Q-null littermates were not signifi  cantly diff  erent (unpub-
lished data). In fact, no signifi  cant diff  erence for any lineage 
tested was observed, including the B, NK, NKT, CD4  +   T, or 
CD8  +   T cells, or mDC subsets in either young or old mice 
(unpublished data). Therefore, Ly49Q defi  ciency appears to se-
lectively aff  ect pDC development and homeostasis, albeit only 
modestly. Young mice (5  –  8 wk old) were chosen for all func-
tional experiments. 
  Severe defect in TLR9-induced IFN-     production 
by Ly49Q-null pDCs 
  To determine the eff  ect of Ly49Q defi  ciency on pDC activa-
tion and subsequent cytokine production, the response of 
Ly49Q-null pDCs to TLR9 agonists was evaluated. Splenic 
pDCs were isolated from WT and Ly49Q-null littermates us-
ing mPDCA-1  –  conjugated magnetic beads, cultured over-
night in various concentrations of CpG-ODN, and the 
supernatant was assayed for IFN-    . Remarkably, Ly49Q-null 
pDC supernatants yielded approximately fi  vefold lower levels 
of IFN-     relative to supernatants from identically treated WT 
pDCs (  Fig. 4 A  ).   This fi  nding is consistent with the earlier ob-
servation that Ly49Q binding to H-2K  b   is necessary for TLR9-
mediated IFN-     secretion (  Fig. 1 A  ). In parallel, Ly49Q-
defi  cient pDCs showed a signifi  cant defect in IL-12 secretion 
in response to CpG-ODN compared with WT pDCs (  Fig. 4 
B  ). The IL-12 defect was not as pronounced as that observed 
for IFN-     but is consistent with the decrease in IL-12 produc-
tion observed upon mAb-mediated blockade of Ly49Q  –  H-
2K  b   interactions (  Fig. 1 B  ). In contrast, TNF-     and IL-6 
    Figure 3.         Age-dependent increase in pDC proportion in Ly49Q-
null mice.   (A) pDC size and morphology. pDCs were sorted as CD11c  + B
220  + CD11b     DX5     CD3     CD19       cells from the spleen and cytocentri-
fuged on microspcope slides directly as resting pDCs or after incuba-
tion with 3   μ  g/ml CpG for 16 h. Slides were then stained with Giemsa 
solution. Bar, 5   μ  m. (B) Localization of splenic pDCs. Sections of spleen 
isolated from untreated young mice or mice injected i.v. with 10   μ  g/ml 
CpG 24 h earlier were stained with fl  uorescently labeled mAb to CD19 
(B cells; green), CD3 (T cells; blue), and BST2 (pDCs; red). Bar, 50   μ  m. 
(C) Frequency of pDCs in primary and secondary lymphoid organs. Shown 
are the proportion of pDCs defi  ned as CD11c  + Siglec-H +   cells in lym-
phoid organs of   Ly49q  +/+    (closed bars) and   Ly49q  lox/lox    (open bars) mice 
(6 wk old,   n   = 3; 9 mo old,   n   = 6). A similar pattern was observed with 
BST2 staining (not depicted). Data are presented as the mean of indi-
vidual mice (error bars = SD). Results are representative of at least 
three independent experiments, except for C (9-mo-old mice), which 
was done twice.     3192 L  Y  49Q REGULATION OF   P  DC FUNCTION   | Tai et al. 
tently 5  –  10-fold less than those of WT littermates (  Fig. 4 E  ). 
On the other hand, the sera of both cohorts showed similar 
levels of IL-12 (unpublished data). The normal serum IL-12 
levels detected in Ly49Q-null mice after CpG injection 
were most likely caused by TLR9-mediated IL-12 produc-
tion by cell types other than pDCs (  24  ). A time-course ex-
periment monitoring serum IFN-     levels confi  rmed  that 
although maximal IFN-     levels occur 4  –  6 h after injection 
in WT mice, Ly49Q-null mice failed to attain a similar mag-
nitude of IFN-     levels at any time point assayed (  Fig. 4 F  ). 
Thus, Ly49Q-null mice display an inherent defect in IFN-     
production were not compomised in Ly49Q-defi  cient pDCs 
(  Fig. 4, C and D  ). Thus, Ly49Q-defi  cient pDCs possess an in-
trinsic defect in IFN-     production after stimulation with 
TLR9 agonists in vitro. 
  Injection of mice with CpG-ODN leads to a rapid ele-
vation of serum IFN-     peaking at 6 h after treatment that is 
mediated by pDCs (  23  ). To determine whether the in vitro 
cytokine defect of Ly49Q-null pDCs had in vivo conse-
quences, mice were injected with CpG-ODN, and serum 
IFN-     levels were evaluated after 6 h. Importantly, IFN-     
serum levels in CpG-injected Ly49Q-null mice were consis-
    Figure 4.         Ly49Q-null pDCs display an IFN-     production defect in response to CpG-ODN.   (A – D)  IFN-    production by isolated pDCs after CpG-
ODN stimulation. pDCs were isolated with mPDCA-1 microbeads from Ly49Q-null and -WT mice and cultured overnight in the presence of the indicated 
concentrations of CpG-ODN. Culture supernatants were assayed by ELISA for IFN-     (A), IL-12p70 (B), TNF-     (C), or IL-6 (D). (E) Induction of serum cyto-
kines by CpG-ODN injection. Ly49Q-null and -WT littermates were injected with CpG-ODN + DOTAP, and blood samples were taken after 6 h for IFN-    
ELISA. Uninjected mice served as controls. Each symbol represents a single mouse. (F) Serum IFN-     time course after CpG-ODN stimulation. Ly49Q-null 
and -WT littermates were injected with CpG-ODN + DOTAP, and blood was collected periodically over 36 h. Serum IFN-     levels were deduced by ELISA 
from three mice of each genotype for each time point. Data are representative of experiments done at least three times independently (error bars = SD). 
(G) pDCs were isolated from H-2K  b D b    –  null or   –  WT (B6) mice and treated as in A. Horizontal bars represent means.     JEM VOL. 205, December 22, 2008 
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(unpublished data). Collectively, these data suggest that the sig-
naling pathways downstream of TLR9 that induce expression 
of CD86/class II MHC are diff  erent from those that lead to 
IFN-     production such that Ly49Q signaling modulates only 
the latter responses in pDCs. 
  TLR7-mediated cytokine secretion is defective 
in Ly49Q-null mice 
  To further characterize the extent of the defect in Ly49Q-
null pDC cytokine responses, a distinct TLR pathway was 
evaluated. In addition to high levels of TLR9, pDCs also ex-
press TLR7, which can recognize single-stranded RNA mo-
tifs represented by such viruses as infl   uenza and vesicular 
stomatitis virus. Similar to CpG-ODN stimulation, infection 
of isolated pDCs with infl  uenza virus resulted in high levels 
of secreted IFN-    , as previously reported (  6  ). Ly49Q-null 
pDCs produced fi  vefold less IFN-     and threefold less IL-12 
than WT pDCs in response to infl  uenza (  Fig. 7, A and B  ).   
production in vivo, and IFN-     and IL-12 responses to CpG-
ODN can be uncoupled in these mice. Although the ab-
sence of the receptor leads to clear defects in cytokine 
production, the eff   ect of loss of the ligand is unknown. 
Thus, pDCs were isolated from H-2K  b  D  b    –  null mice and were 
stimulated for IFN-     production by CpG-ODN. H-2K  b  D  b    –
  null  pDCs showed     50% reduction in IFN-     secretion 
compared with WT pDCs (  Fig. 4 G  ). These results are con-
sistent with the hypothesis that Ly49Q  –  MHC interactions 
are necessary for cytokine production in pDCs, whereas the 
inhibition of IFN-     secretion was not as pronounced as for 
Ly49Q-null pDCs. Possible reasons for this diff  erence may 
include the mouse strain background or that Ly49Q may 
have other ligands in addition to H-2K  b  . 
  To address the question of whether Ly49Q/MHC inter-
act in cis or trans to regulate pDC function, Ly49Q-null mice 
were crossed to H-2K  b  D  b    –  null mice, and the resulting F1 
mice were intercrossed to generate the four possible null 
phenotypes. pDCs from WT mice stain positively with solu-
ble H-2K  b  /OVA tetramer, and this binding is caused by 
Ly49Q, as shown by the complete absence of binding in 
Ly49Q-null mice and by previous blocking experiments with 
anti-Ly49Q mAb (  Fig. 5 A  , compare the top two dotplots) 
(  21  ).   In the absence of H-2K  b   expression, binding of the 
H-2K  b   tetramer is much stronger but still Ly49Q dependent 
(  Fig. 5 A  , compare the bottom two dotplots). Diff  erential 
tetramer binding was not caused by diff  erences in Ly49Q ex-
pression between WT and H-2K  b  D  b    –  null mice, as pDCs 
from both mouse strains expressed similar levels of Ly49Q 
(  Fig. 5 B  ). These results suggest that in WT pDCs, cis inter-
actions between Ly49Q and endogenous H-2K  b   are inhibit-
ing binding of soluble H-2K  b   tetramer to Ly49Q. 
  Normal TLR9 expression and pDC activation 
in Ly49Q-defi  cient mice 
  Although the in vitro mAb-mediated blocking experiments are 
consistent with the phenotype of Ly49Q-null pDCs in vitro 
and in vivo, the defect in TLR9-induced cytokine production 
might be the result of factors other than the absence of Ly49Q. 
First, Ly49Q defi  ciency may have caused down-regulation of 
TLR9. To exclude this possibility, TLR9 expression was de-
termined by RT-PCR and intracellular fl  ow cytometry given 
the localization of TLR9 in endosomes. TLR9 levels were 
measured and found to be similar in both Ly49Q-WT and 
-null pDCs ( Fig. 6 A  and not depicted), suggesting that Ly49Q-
null pDCs have an equal potential to bind CpG-ODN.  Second, 
the almost complete lack of IFN-     secretion by Ly49Q-null 
pDCs may be caused by an inability of the cells to become fully 
activated. Downstream activation events in pDCs both in vivo 
(  Fig. 6 B  ) and in vitro (  Fig. 6 C  ) after CpG-ODN challenge 
were assessed by fl  ow cytometry analysis of CD86 and class II 
MHC surface expression, and were found to be normal. The 
percentage of pDCs expressing CD86 and the level of CD86 
on pDCs were similar between WT and Ly49Q-null pDCs after 
CpG treatment, even over an extended range of doses (  Fig. 6, 
B and C  ). Similar observations were made for class II MHC 
    Figure 5.         Ly49Q binds to H-2K  b   in cis.   (A) pDCs were isolated from the 
spleens of mice with the indicated genotypes with mPDCA-1 microbeads. 
Isolated pDCs were stained with PE  –  H-2K  b  /OVA tetramer and allophycocya-
nin  –  anti-BST2 mAb and were analyzed by fl  ow cytometry. Cells are gated 
on pDCs. The percentage of cells positively staining with PE  –  H-2K  b /OVA  is 
shown. (B) Ly49Q levels on MHC-defi  cient pDCs. Splenocytes from the indi-
cated strains (WT is B6) were stained for BST2, Siglec-H, and Ly49Q (NS34). 
The level of Ly49Q expression on BST2  + Siglec-H +   cells is shown (shaded 
histogram). The open histogram represents the secondary reagent alone.    3194 L  Y  49Q REGULATION OF   P  DC FUNCTION   | Tai et al. 
IFN-     production observed in Ly49Q-null mice may also 
lead to diminished pDC responses and altered innate im-
munity to DNA viruses like MCMV. In keeping with this, 
purifi  ed Ly49Q-null pDCs produce approximately three-
fold less IFN-     than WT pDCs in response to overnight 
MCMV infection in vitro (  Fig. 8 A  ).   The MCMV/pDC 
co-culture experiment confi  rms, independently of CpG-
ODN, that pDCs from Ly49Q-null mice display defective 
IFN-     production when triggered through TLR9. 
  To confi   rm these fi   ndings in vivo, Ly49Q-null mice 
were infected with MCMV. As shown in   Fig. 8 B  , splenic 
viral titers were consistently higher in Ly49Q-null mice ver-
sus WT control animals. Although not all experiments 
showed a statistically signifi  cant diff  erence between the two 
cohorts (e.g., day 3, 6,000 PFU;   Fig. 8 B  ), the detection of 
impaired viral immunity may be complicated by the suscep-
tible Ly49H        129 background of these mice (  26  ). Because 
Active and inactivated infl  uenza virus treatments gave similar 
results (unpublished data). In contrast, CD86 and class II 
MHC up-regulation of isolated pDCs in response to a TLR7 
agonist was normal in Ly49Q-null pDCs (  Fig. 7 C   and not 
depicted). Therefore, TLR7-induced cytokine secretion is 
also attenuated in Ly49Q-null pDCs. 
  Ly49Q-defi  cient mice exhibit diminished protection 
to mouse CMV (MCMV) infection 
  The defect in IFN-     production seen in Ly49Q-null mice 
after TLR9 stimulation may have deleterious consequences 
during immune responses against pathogens that are de-
tected through TLR9. Previous studies have reported that 
TLR9 defi   ciency promotes increased susceptibility to 
MCMV infection, as manifested by higher viral loads and 
defective production of multiple cytokines, including type 
I IFN (  24, 25  ). As such, the defect in TLR9-dependent 
    Figure 6.         Normal TLR9 and CD86 expression by Ly49Q-null pDCs.   (A) Splenocytes from Ly49Q-null and -WT mice were stained for Siglec-H and 
BST2, and were then permeabilized and stained for intracellular TLR9 or with an isotype control mAb. TLR9 (shaded histogram) or control (open histo-
gram) expression on Siglec-H  + BST2 +   cells is shown. (B) In vivo activation of pDCs by CpG-ODN. Ly49Q-null and -WT littermates were injected with CpG-
ODN + DOTAP. Uninjected mice served as controls. After 6 h, the splenocytes were isolated and stained for Siglec-H, BST2, and CD86, and were analyzed 
by fl  ow cytometry. The percentage of CD86  +   pDCs after 6 h is shown (error bars = SD). (C) In vitro activation of pDCs by CpG-ODN. pDCs from Ly49Q-null 
and -WT mice were isolated with mPDCA-1 microbeads and cultured overnight in the presence of the indicated concentrations of CpG-ODN. The follow-
ing day, the CD11c  + B220 +   cells were analyzed by fl  ow cytometry for CD86 surface expression. MFI (left) and the percentage of positive cells (right) are 
shown as the means of triplicate cultures   ±   SD. Data are representative of at least three independent experiments.     JEM VOL. 205, December 22, 2008 
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pressed on pDCs, in contrast to all other Ly49s. We have 
previously shown, using the BWZ lacZ-based reporter cell 
assay, that H-2K  b   is a high affi   nity ligand for Ly49Q (  21  ). In 
this study, we confi  rm the specifi  city of Ly49Q for H-2K  b   in 
a functional assay (IFN-     secretion) using fresh ex-vivo 
pDCs. Remarkably, Ly49Q  –  H-2K  b   interactions appear to 
be required for optimal TLR7- and TLR9-dependent stim-
ulation of cytokine production by pDCs, as indicated by the 
drastic reduction in CpG-mediated IFN-     and IL-12 secre-
tion upon mAb-mediated blockade of either Ly49Q recep-
tor or its cognate ligand, H-2K  b  . In further support of this 
the   Ly49h   gene conferring resistance to MCMV in B6 mice 
(  27, 28  ) is   <  300 kb away from the targeted   Ly49q  lox     allele, 
these experiments could not be repeated on the MCMV-
resistant B6 background at this time. Notwithstanding this, 
the majority of experiments did reveal a statistically signifi  -
cant increase in Ly49Q-null MCMV titers when performed 
using either an early time point (1.5 d after infection) or a 
low initial MCMV inoculum (600 PFU), or both (  Fig. 8 B  ). 
In agreement with our fi  ndings, TLR9-null mice on a sus-
ceptible background (Ly49H        BALB/c) display a similarly 
small but signifi   cant increase in splenic viral titers after 
MCMV infection (  24  ). Serum IFN-     and IL-12 levels peak 
at 36 h after MCMV infection. At this time point, Ly49Q-
null mice display normal levels of IFN-     (  Fig. 8 C  ) and 
slightly decreased IL-12p70 levels (  Fig. 8 D  ). This suggests 
that in addition to pDCs, other cell types can contribute to 
serum IFN-    /IL-12 levels by 36 h after infection. Collec-
tively, these experiments demonstrate that Ly49Q-null pDCs 
exhibit a functional defi  ciency in IFN-     production in re-
sponse to MCMV infection in vitro, and this translates into 
an enhanced susceptibility of Ly49Q-null mice to MCMV 
infection in vivo. 
    DISCUSSION   
    Ly49q   is a highly conserved   Ly49   found in all mouse strains 
characterized to date (  16  ). Ly49Q is also unique in being ex-
    Figure 7.         TLR7-induced cytokine production is defective in 
Ly49Q-null pDCs.   (A and B) In vitro activation of pDCs by infl  uenza vi-
rus. pDCs from Ly49Q-null and -WT mice were isolated using mPDCA-1 
microbeads and cultured overnight in the presence or absence of 20 hem-
agglutinin units of infl  uenza virus. Culture supernatants were assayed by 
ELISA for IFN-     (A) or IL-12p70 (B). Each symbol represents a single 
mouse. Horizontal bars represent means. (C) In vitro activation of pDCs by 
imiquimod. pDCs from Ly49Q-null and -WT mice were isolated using mP-
DCA-1 microbeads and cultured overnight with the indicated concentra-
tions of imiquimod. The following day, CD11c  + B220 +   cells were stained 
with FITC  –  anti-CD86 and analyzed by fl  ow cytometry for CD86 surface 
expression. MFI (left) and the percentage of positive cells (right) are 
shown as the means of triplicate cultures   ±   SD. Data are representative of 
at least three independent experiments.     
    Figure 8.         Reduced anti-MCMV responses by Ly49Q-null mice.   
(A) Decreased MCMV-induced IFN-     secretion by pDCs in vitro. Splenic pDCs 
were isolated with mPDCA-1 microbeads and cultured overnight in the 
presence of 200 PFU/ml of MCMV. Supernatants were harvested the follow-
ing day. Supernatants were assayed for IFN-     levels by ELISA. (B) Greater 
MCMV proliferation in Ly49Q-null mice. Ly49Q-null and -WT mice were 
challenged with 600 or 6,000 PFU MCMV. After 1.5 or 3 d, spleens were 
harvested and viral titer was determined using BALB/c mouse embryo fi  bro-
blasts. Each symbol represents a single mouse. Data are representative of at 
least three independent experiments. Horizontal bars represent means. 
(C and D) Littermates of the indicated genotypes were infected with 6,000 PFU 
MCMV i.p., and serum samples were taken at the indicated time points after 
infection. IFN-     (C) or IL-12p70 (D) levels were determined by ELISA (  n   =  4 
per time point). The means of individual mice   ±   SD are shown.    3196 L  Y  49Q REGULATION OF   P  DC FUNCTION   | Tai et al. 
response to receptor engagement, resulting in the recruitment 
of SHP-1/2 (  29  ). Ly49-associated SHP-1/2 are then thought 
to antagonize stimulatory signals initiated through ITAM-
bearing adaptor molecules such as DAP12. For example, the 
ITIM-bearing Ly49G receptor has been demonstrated to 
suppress DAP12-dependent Ly49D-mediated cytotoxicity 
and cytokine production (  30  ). Notably, the ability of the 
Ly49Q ITIM to associate with SHP-1/2 is intact, at least in 
reconstitution experiments using transfected cell lines (  10  ). 
Thus, if Ly49Q is an inhibitory receptor, how does it func-
tion to relay TLR7/9-induced signals or amplify TLR7/9-
mediated signal transduction? Interestingly, there are clues 
from experiments performed using DAP12-null mice that 
may off  er a possible mechanism. Specifi  cally, DAP12-null 
pDCs were reported to produce signifi  cantly more IFN-     af-
ter CpG-ODN stimulation (  31  ), as opposed to the decreased 
response of Ly49Q-null mice. The resulting conclusion was 
that DAP12 may negatively regulate TLR7/9 signal trans-
duction and, in turn, that DAP12-coupled receptors on pDCs 
may inhibit IFN-     secretion upon cross-linking. In support 
of this hypothesis, the pDC-expressed and DAP12-associated 
surface proteins Nkp44 and Siglec-H do indeed inhibit CpG-
induced IFN-     secretion upon mAb-mediated ligation (  12, 
22  ). In this respect, macrophages and pDCs are functionally 
similar, as macrophages from DAP12-null mice produce 
more cytokines after TLR engagement (  32  ). Furthermore, 
the DAP12-coupled TREM2 surface receptor appears to de-
liver constitutive inhibitory signals in macrophages (  33  ). 
  The apparent stimulatory role of Ly49Q in pDCs could 
be caused by antagonism of inhibitory DAP12 signal trans-
duction by SHP-1/2 recruited as a result of Ly49Q  –  MHC 
interaction. In this model, DAP12 signaling would be consti-
tutive like TREM2 function in macrophages (  33  ). Although 
the convergence point between the DAP12 and TLR9 sig-
naling pathways is unclear, another possibility is that down-
stream Ly49Q signaling molecules may directly regulate the 
TLR9 signaling cascade independently of DAP12 function. 
A third mechanism behind Ly49Q function may include an 
alternative signaling pathway found in pDCs, one which is 
distinct from canonical inhibitory Ly49 signaling in NK cells 
and does not involve the recruitment of tyrosine phospha-
tases. Evidence for this possibility includes Ly49Q-transfected 
macrophage cell lines, which show an increase in tyrosine-
phosphorylated proteins in whole-cell lysates after mAb-me-
diated cross-linking of Ly49Q (  10  ). 
  The mechanistic link between Ly49Q function and IFN-     
secretion is unknown. However, an interesting parallel may 
exist between NK cells and pDCs in this regard. Two reports 
have suggested that mature splenic NK cells lacking all self-
specifi   c MHC-binding inhibitory receptors (NKG2A and 
Ly49C/I in B6 mice) are hyporesponsive with respect to the 
killing of target cells and the production of IFN-     (  34, 35  ). 
Thus, B6 strain NK cells expressing NKG2A and/or Ly49C/I 
have been referred to as being   “  licensed  ”   or   “  armed.  ”   It is 
tempting to speculate that pDCs like NK cells may also re-
quire the expression of at least one self-specifi  c MHC-binding 
hypothesis, purifi  ed pDCs cultured in the presence of low 
concentrations of CpG-ODN produced high levels of IFN-     
when stimulated on immobilized Ly49Q mAb or H-2K  b  /Ig 
fusion protein but not in the presence of CpG-ODN alone. 
Collectively, these fi  ndings demonstrate that Ly49Q  –  class I 
MHC interactions positively regulate TLR signals and subse-
quent cytokine production in pDCs. 
  In confi  rmation of the in vitro mAb blocking experi-
ments, Ly49Q-null mice show a severe defect in systemic 
IFN-     levels (75  –  100% reduction) upon challenge with 
CpG-ODN. This defect is likely caused by the hyporespon-
siveness of Ly49Q-null pDCs, as purifi  ed pDCs from these 
mice exhibit similarly decreased IFN-     responses upon CpG-
mediated stimulation in isolation. Ly49Q-null pDCs also 
show a defect in the production of IFN-     after overnight 
culture with MCMV. Both CpG-ODN and MCMV stimu-
late IFN-     production by pDCs in a TLR9-dependent man-
ner (  24  ). However, TLR9 mRNA and protein expression 
levels in Ly49Q-null pDCs are normal, as deduced by semi-
quantitative RT-PCR and intracellular staining, respectively. 
The Ly49Q-null defect similarly aff  ects TLR7, as TLR7-
dependent stimulation of isolated Ly49Q-null pDCs results in 
highly decreased levels of IFN-     relative to WT pDCs. No-
tably, in addition to IFN-     levels, Ly49Q-null pDCs also ex-
hibit decreased IL-12p70 levels in response to CpG-ODN or 
infl  uenza stimulation. Thus, Ly49Q-null pDCs possess an in-
trinsic cytokine production defect in response to TLR7 and 
TLR9 agonists. Interestingly, however, the activation status 
of Ly49Q-null pDCs seems normal over a wide range of CpG-
ODN concentrations, at least with respect to up-regulation 
of CD86 and class II MHC surface expression, TNF-     and 
IL-6 production, morphological change, and migration 
within the spleen. This suggests that TLR9 stimulation results 
in multiple signaling pathways leading to pDC activation, but 
that Ly49Q regulates only the signal transduction pathway 
leading to IFN-     secretion. 
  The phenotype of pDCs from Ly49Q-null mice is similar 
to that observed for Ly49Q-negative pDCs from WT bone 
marrow. Omatsu et al. found that Ly49Q-negative pDCs pro-
duced signifi  cantly less IFN-    /     than their Ly49Q-positive 
counterparts when cultured in the presence of CpG-ODN or 
Sendai virus (  19  ). In contrast, Kamogawa-Schifter et al. ob-
served comparable IFN-     production levels from the two 
pDC subsets in vitro after stimulation with CpG-ODN (  11  ). 
It is not immediately clear why there is a discrepancy in IFN-     
production among Ly49Q-positive versus -negative pDCs in 
these two studies, as similar isolation procedures and the same 
mouse strain (BALB/c) were used. The data presented in this 
paper agree with the former study, in that the ability of pDCs 
to produce large amounts of IFN-     appears to depend on 
Ly49Q expression and function. 
  The positive regulation of TLR9 signaling by Ly49Q is at 
fi  rst counterintuitive, given that the ITIM-bearing Ly49Q 
receptor has the characteristics of an inhibitory Ly49 family 
member. Similar Ly49 receptors expressed by NK cells un-
dergo tyrosine phosphorylation of their cytoplasmic ITIM in JEM VOL. 205, December 22, 2008 
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stimulatory in nature. Although this is somewhat paradoxi-
cal, it is nonetheless consistent with the reported counterreg-
ulatory function of DAP12-coupled receptors in pDCs, 
which appear to be inhibitory. 
  MATERIALS AND METHODS 
  Mice.     129S1 and B6 mice were purchased from the Jackson Laboratory. 
  H-2Kb  tm1  H-2Db  tm1     (K  b  D  b  -KO) mice on a B6 background were purchased from 
Taconic. Mice were maintained and bred in the Clinical Research Institute 
of Montr  é  al (IRCM) specifi  c pathogen-free animal facilities. All manipula-
tions performed on animals were in accordance with IRCM guidelines and 
were approved by the IRCM Animal Ethics Committee. Unless otherwise 
mentioned, all mice used for experiments were 5  –  8 wk of age. 
  Generation of Ly49Q-null mice.     We previously identifi  ed 129S6 bacte-
rial artifi  cial chromosome (BAC) clones containing   Ly49q  1     (  15  ). A 10-kb 
segment centered on exon 2 was retrieved from BAC 34o6 into the pMCIT-
KpANhe vector by lambda red  –  mediated recombineering in EL350 cells, 
as previously described (  37  ). To complete the targeting construct, a fl  oxed 
PGK-neomycin cassette from PL400 was inserted into a unique StuI site in 
exon 2. The complete targeting construct sequence was confi  rmed. R1 ES 
cells (129Sv  ×   129Sv-CP) were electroporated with NotI-linearized targeting 
vector DNA and were then selected in G418. Homologous recombination 
in ES cells was assessed by Southern blotting. A homologous recombination 
effi   ciency of 1% was observed (6 out of 600). The germline competency of 
these clones was confi  rmed by generating heterozygous founder mice, which 
were then bred to achieve Ly49Q  neo/neo   homozygosity. An ES clone carry-
ing a properly targeted   Ly49q  1    neo     allele was electroporated with a CMV-Cre 
vector (a gift from D. Lohnes, University of Ottawa, Ottawa, Canada) and 
screened for neomycin deletion by PCR.   Ly49q  1    neo     and   Ly49q  1    lox     founder 
mice were generated by the IRCM MicroInjection Service. Founder mice 
that could transmit the targeted   Ly49q  1     allele to the germline were bred to 
129S1 females to maintain a 129 background, which was confi  rmed for the 
  Ly49   locus by 4E5 versus 12A8 staining of NK cells, as previously described 
(  38  ). The resulting heterozygous mice were bred, and homozygous WT 
and Ly49Q-null littermates were used in all experiments unless otherwise 
indicated. Southern blot analysis for the   Ly49q  neo     allele was performed us-
ing an intron 4 probe cloned into pCR2.1TOPO (Invitrogen), prepared by 
amplifying BAC 34o6 DNA with 5    -TATGACTTCTTGGAGAGAGT-3     
(sense primer) and 5    -TTCACGTGGGCCTAGAATTT-3     (antisense primer). 
The   Ly49q  1    lox     allele was detected by PCR with 5    -CCTAAAAGTA-
ATTGCTGTGACTATT-3     (sense primer) and 5    -CTTTCTAAC-
TAGCTAACAACAG-3     (antisense primer). A substitute reverse primer, 
5    -CCGAATATCATGGTGGAAAATGGC-3    , was used to amplify the 
  Ly49q  1    neo     allele. The following PCR cycling parameters used were: 94  °  C for 
30 s, 55.5  °  C for 30 s, and 72  °  C for 30 s, for 35 cycles. 
  pDC isolation and in vitro activation.     Mouse spleens were injected 
with collagenase (Roche), minced, and incubated for 20 min at 37  °  C. Af-
ter incubation, splenocytes were crushed in cold PBS-BSA-EDTA and 
strained through a 70-  μ  M fi  lter. RBCs were removed by incubation with 
ACK lysis buff  er for 5 min at 4  °  C. Isolated splenocytes were maintained 
throughout the procedure in cold PBS-BSA-EDTA. Anti  –  mPDCA-1  –
  conjugated microbead (Miltenyi Biotec) labeling was performed according 
to the manufacturer  ’  s protocol. Isolated pDCs were seeded at 100,000 cells 
per well in 200   μ  l of pDC medium (RPMI 1640, 10% FBS, pen/strep,   l-
  glutamine, 2-    -mercaptoethanol) and cultured for 16 h at 37  °  C in 5% 
CO  2   in a humidifi  ed atmosphere in the presence of CpG-ODN 10103 or 
2336 (Coley Pharmaceuticals), imiquimod, MCMV, or infl  uenza at the 
indicated concentrations/PFU/hemagglutinin units. Supernatants were 
collected and frozen. 
  In vivo pDC activation.     Mice were injected through the tail vein 
with CpG-ODN plus 1,2-dioleoyloxy-3-trimethylammonium-propane 
inhibitory receptor to become fully functional IFN-     pro-
ducers. This hypothesis is consistent with the hyporespon-
siveness observed for immature Ly49Q-negative pDCs (  19  ). 
Because Ly49Q binds with high affi   nity to H-2K  b  , a self-
specifi   c determinant expressed in 129 strain Ly49Q-null 
mice, the lack of a self-MHC  –  specifi  c inhibitory signal dur-
ing pDC development in Ly49Q-null mice may render these 
cells anergic. However, the recapitulated phenotype using 
WT pDCs in mAb blocking experiments ( Fig. 1 ) argues against 
Ly49Q-null pDCs being anergic. 
  Type I IFN is indispensable for resistance to a wide range 
of viruses, as shown by studies using IFN-    /    R-null mice 
(  36  ). Ly49Q-null mice, which are on the Ly49H        129 back-
ground, also display a severe IFN production defect, as well 
as a consistent and statistically signifi  cant increase in suscepti-
bility to MCMV. However, the susceptibility of Ly49Q-null 
mice to virus infection is not as profound as that observed in 
IFN-    /    R-null mice. There are several possible reasons for 
this observation. First, although the magnitude of the IFN-     
response to CpG-ODN challenge in WT mice far exceeds 
that of Ly49Q-null mice, the latter still yield up to 15  –  25% 
of WT serum IFN-     levels. This lower yet detectable IFN-     
production may be suffi   cient to mount resistance to viral in-
fection. This hypothesis is consistent with the phenotype of 
Ly49H  +   B6 mice, which produce low levels of IFN-     (  6  ) but 
are nonetheless suffi   cient for protection against MCMV and 
other viruses. In agreement with our study, TLR9-null mice 
on a BALB/c (MCMV susceptible; Ly49H       ) background 
also only show a small increase in susceptibility (  24  ), as would 
be expected if Ly49Q does indeed regulate TLR signaling. 
Furthermore, normal systemic IFN-     levels were observed 
in Ly49Q-null mice 36 h after MCMV infection despite their 
defective IFN-     responses to synthetic CpG-ODN. There-
fore, although pDC cytokine production is compromised in 
Ly49Q-defi  cient mice and does confer limited susceptibility 
to viral infection, the residual capacity of these mice to pro-
duce antiviral cytokines probably aff  ords suffi   cient protec-
tion. Whether these residual cytokines are made by Ly49Q-
null pDCs or other cell types is not clear. 
  Based on the data generated from mAb-mediated block-
ing assays and functional analyses of Ly49Q-null pDCs in vi-
tro, as well as in vivo analyses of Ly49Q-null mice, we 
conclude that pDC function, in particular IFN-     secretion, 
is regulated by class I MHC. The ability of pDCs to recog-
nize class I MHC molecules is imparted by the lectin-like 
Ly49Q receptor, which in turn potentiates the capacity of 
pDCs to produce cytokines in response to TLR7 and TLR9 
agonists. Loss of this self-recognition mechanism results in 
severe defects in IFN-     and IL-12 production by pDCs. 
Thus, Ly49Q  –  MHC interactions positively regulate pDC 
cytokine production triggered through TLR. Therefore, the 
down-regulation of class I MHC by certain viruses like 
MCMV could also result in the attenuation of pDC antiviral 
defense mechanisms in addition to evasion of CD8  +   T cell 
responses. Interestingly, despite bearing a consensus ITIM 
sequence, the function of Ly49Q on pDCs appears to be 3198 L  Y  49Q REGULATION OF   P  DC FUNCTION   | Tai et al. 
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(DOTAP; Roche) preparation (170   μ  l CpG-ODN diluted in sterile PBS 
plus 30   μ  l DOTAP) or imiquimod (R-837; InvivoGen) in 200   μ  l PBS. Mice 
were bled through the cheek vein at the indicated time points after injection. 
Serum was analyzed by ELISA. 
  Virus infections.     Infl  uenza strain A HK X31 H3N2 was a gift from T. Watts 
(University of Toronto, Toronto, Canada). MCMV (Smith strain) prepara-
tion, injection, and plaque assay were performed as previously described (  39  ). 
  ELISAs.     Mouse IFN-     was determined by sandwich ELISA. In brief, 96-
well microtiter plates were coated overnight at 4  °  C with 5   μ  g/ml of rat 
anti  –  mouse IFN-     antibody (RMMA-1; PBL Biomedical Laboratories) di-
luted in 0.1 M of sodium carbonate buff  er. Wells were blocked for 1 h with 
PBS/10% FBS and incubated for 2 h with samples or a recombinant mouse 
IFN-     standard (Sigma-Aldrich). IFN-     was detected with 100 ng/ml of 
polyclonal rabbit anti  –  mouse IFN-     antibody (PBL Biomedical Laborato-
ries) for 24 h at room temperature, washed, and incubated for 1 h with a 
donkey anti  –  rabbit IgG conjugated to horseradish peroxidase (GE Health-
care), followed by 20 min in 3,3    ,5,5    -tetramethylbenzidine substrate 
(Sigma-Aldrich), and 1 M H  2  SO  4   was added to stop the reaction. Between 
incubations, plates were washed three times with PBS/0.05% Tween-20. 
Optical density was read at 450 nm with a microtiter plate reader (MDS An-
alytical Technologies). IL-12p70, IL-6, and TNF-     production by pDCs 
was assayed using commercial ELISA kits (BD). 
  Immunofl  uorescence and FACS analysis.     The following FACS mAbs 
were used: biotin-440c (anti  –  Siglec-H; Cell Sciences), allophycocyanin  –
  mPDCA-1 (anti-BST2; Miltenyi Biotec), FITC-CD86, 2E6 (anti-Ly49Q; 
eBioscience), allophycocyanin-B220, PE-CD11c, and streptavidin-PE were 
purchased from BD. NS-34 (anti-Ly49Q) was prepared as previously de-
scribed (  10  ). PE-conjugated H-2K  b  /OVA tetramer contains human     2 mi-
croglobulin and was purchased from Beckman Coulter. For all FACS 
analyses, cells were fi  rst washed in FACS buff  er (PBS, 0.5% BSA, 0.02% 
NaN  3  ), and were then incubated for 20 min at 4  °  C with fl  uorochrome-con-
jugated antibodies. Two-step staining involved an additional incubation for 
20 min with the appropriate secondary antibody at 4  °  C, followed by a wash 
in FACS buff  er. Stained cells were analyzed with a fl  ow cytometer (FACS-
Calibur; BD). Three-color immunofl   uorescent staining with biotin  –  rat 
anti  –  mPDCA-1 plus streptavidin-Alexa Fluor 594, hamster anti-CD3     (BD) 
plus Alexa Fluor 647  –  goat anti  –  hamster IgG (Invitrogen), and FITC  –  anti-
CD19 (BD) was performed on slide-mounted 10-  μ  m spleen sections from 
untreated and CpG-ODN  –  injected mice. Slides were viewed on a confocal 
microscope (Axiovert 100M; Car Zeiss, Inc.). 
  Giemsa staining.     Fresh or CpG-ODN  –  cultured pDCs were cytocentri-
fuged onto glass slides, fi  xed in methanol for 10 min, and air dried. Slides 
were stained with modifi  ed Giemsa stain solution (Sigma-Aldrich) diluted 
1:10 in distilled H  2  O for 10 min, rinsed with distilled H  2  O, and mounted. 
Pictures were obtained with a microscope (Axiophot; Carl Zeiss, Inc.). 
  Statistical analysis.     Unless otherwise indicated, all P values were calcu-
lated with the two-tailed Student  ’  s   t   test. 
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